Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team.

S, Staszewski; J, Morales-Ramirez; KT, Tashima; A, Rachlis; D, Skiest; J, Stanford; R, Stryker; P, Johnson; DF, Labriola; D, Farina; DJ, Manion; NM, Ruiz

doi:10.1056/nejm199912163412501

Public

Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team.

Shared by NobleBlocks on Dec 1, 1999 • 12:00 AM UTC

Authors:

Staszewski S

Morales-Ramirez J

Tashima KT

Abstract

<h4>Background</h4>Efavirenz is a nonnucleoside reverse-transcriptase inhibitor of human immunodeficiency virus type 1 (HIV-1). We compared two regimens containing efavirenz, one with a protease inhibitor and the other with two nucleoside reverse-transcriptase inhibitors, with a standard three-drug ...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!